|

DR30206 Clinical Trials

2 actively recruiting trials

Also known as: DR30206 for Injection

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Zhejiang Doer Biologics Co., Ltd.2

Indications

  • Cancer2
  • Gastrointestinal Cancer1
  • Solid Tumor1

Other2 trials

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
Phase 1
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.